Literature DB >> 9696973

Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma.

K J Paquet1, H A Gad, A Lazar, P Koussouris, M A Mercado, W D Heine, V Jachman-Jahn, W Ruppert.   

Abstract

OBJECTIVE: To review our policy of screening patients at risk of developing hepatocellular carcinoma (HCC), and to present 10 years' experience of hepatic resection for small HCC (< 5 cm).
DESIGN: Retrospective study.
SETTING: Teaching hospital, Germany.
SUBJECTS: 861 patients with hepatic cirrhosis and oesophageal varices of whom 151 (18%) had HCC confirmed histologically; 30 of these tumours (20%) were less than 5 cm in diameter and suitable for resection.
INTERVENTIONS: Segmentectomy (n = 14) bisegmentectomy (n = 10), and oncologically defined wedge resection (n = 6). MAIN OUTCOME MEASURES: Mortality, morbidity, and survival.
RESULTS: 4 patients died within 30 days of liver failure and sepsis (n = 20, liver failure (n = 1), and bronchopneumonia (n = 1). The main beneficial prognostic factors were Child classification, donation of autologous blood, and an encapsulated tumour. The main indicators of a poor prognosis were invasion of the liver, venous invasion, invasion of the resection margin, and the presence of microsatellite tumours and nodules. 12 of the 26 survivors developed recurrences during the first five years postoperatively (46%). Kaplan-Meier survival curves showed that survival at 1 year was 80%, at 3 years 65%, and 5 years 50%, and at 10 years 30%.
CONCLUSION: Hepatic resection is a useful treatment for small HCC, but its success depends on early detection and careful selection of patients.

Entities:  

Mesh:

Year:  1998        PMID: 9696973     DOI: 10.1080/110241598750005868

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  13 in total

1.  Surgery for cirrhotic patients with hepatocellular carcinoma and hypersplenism.

Authors:  K J Paquet
Journal:  Surg Endosc       Date:  2001-01       Impact factor: 4.584

2.  Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?

Authors:  Ronnie Tung Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Kei Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

3.  Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal.

Authors:  R T Poon; S T Fan; I O Ng; J Wong
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

4.  Hepatic vein reconstruction for resection of hepatic tumors.

Authors:  Alan W Hemming; Alan I Reed; Max R Langham; Shiro Fujita; Willem J van der Werf; Richard J Howard
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

Review 5.  Quality of complication reporting in the surgical literature.

Authors:  Robert C G Martin; Murray F Brennan; David P Jaques
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

6.  Preoperative predictors of survival after resection of small hepatocellular carcinomas.

Authors:  Jeffrey D Wayne; Gregory Y Lauwers; Iwao Ikai; Dorota A Doherty; Jacques Belghiti; Yoshio Yamaoka; Jean-Marc Regimbeau; David M Nagorney; Kim-Anh Do; Lee M Ellis; Steven A Curley; Raphael E Pollock; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

7.  Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.

Authors:  Hai-Xia Qin; Ke-Jun Nan; Guang Yang; Zhao Jing; Zhi-Ping Ruan; Chun-Li Li; Rui Xu; Hui Guo; Chen-Guang Sui; Yong-Chang Wei
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

Review 8.  Surgical treatment for liver cancer.

Authors:  Nicole C Tsim; Adam E Frampton; Nagy A Habib; Long R Jiao
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

9.  Perioperative risk assessment for hepatocellular carcinoma by using the MELD score.

Authors:  Spiros G Delis; Andreas Bakoyiannis; Christos Dervenis; Nikos Tassopoulos
Journal:  J Gastrointest Surg       Date:  2009-08-07       Impact factor: 3.452

10.  Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma.

Authors:  Spiros G Delis; Andreas Bakoyiannis; Ioannis Biliatis; Konstantinos Athanassiou; Nikos Tassopoulos; Christos Dervenis
Journal:  HPB (Oxford)       Date:  2009-06       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.